Joe Concha Criticizes Abdul El-Sayed’s Medical Credentials and Advertising Practices
Allegations Against Michigan Senate Candidate Abdul El-Sayed
Fox News contributor Joe Concha has criticized Michigan Senate candidate Abdul El-Sayed, accusing him of misrepresenting his medical credentials. Concha stressed the contrast between the sacrifices made by licensed doctors and El-Sayed’s alleged claims. He emphasized El-Sayed has not saved lives as a licensed doctor, labeling his assertions as deceitful and harmful to the profession.
Concerns Over Health Product Advertising
El-Sayed has been involved in promoting health products while referencing his medical background. Despite his public stance against marketing products with health claims, he hosted a podcast earning him six figures through advertising reads. His advertisers include companies selling supplements and an Israeli metabolism-tracking device scrutinized by health experts.
El-Sayed had assured listeners he would not use his platform to sell health products, yet he used his medical credentials to do just that, similar to criticisms he leveled against Mehmet Oz during Oz’s Senate campaign.
Controversial Advertisements and Product Claims
Among the products El-Sayed promoted were supplements like ‘Moon Juice Brain Dust’ and ‘Royal Jelly Brain Fuel’, which claim cognitive benefits. Experts doubt these claims, suggesting limited scientific backing. Thrive Market, a company El-Sayed endorsed, sells such products and did not comment on these endorsements.
Another product was Lumen, a device offering metabolic insights through breath analysis. Despite its scientific claims, experts like Nicholas Tiller criticize it for prioritizing marketing over actual science.
Public Records and Credentials
Public records show El-Sayed, despite his medical degree and doctorate in public health, never held a medical license or completed a residency. These details were first reported by the New York Post.
The El-Sayed campaign did not respond to requests for comments regarding the allegations or advertisement controversies.